BioGeneration Ventures logo

BioGeneration Ventures

Investment Focus

Countries

Headquarters

Naarden, NL

Investment Focus

Biotech, Life Sciences, Pharmaceuticals, Therapeutics, Oncology, Immunology, Nephrology, Chronic Diseases, Cell Therapy, Synthetic Lethality in Cancer

Investment Thesis

BioGeneration Ventures (BGV) is a venture capital firm specializing in seed investments in innovative early-stage European life sciences companies. BGV typically acts as the lead investor, focusing on biotech companies developing disruptive solutions for high unmet medical needs. BGV is the early-stage strategy of the Forbion-BGV platform of funds, which also includes Forbion Ventures and Forbion Growth. The firm supports biotech companies throughout all stages of development, from company formation (Build, Seed, Series A) through company building (Build, Enable, Series A-B) and company expansion (Crossovers, VIPE/PIPE, Series B/C). They look for opportunities to translate rough scientific ideas into therapeutic products, emphasizing patient impact and attracting additional investment.

Deal Pipeline

Track your relationship with BioGeneration Ventures and manage next steps in your fundraising CRM.


Get Matched with VCs

Use GRID's AI-powered VC matcher to find investors that are the best fit for your startup based on sector, stage, geography, and more.

Get AI-Powered Matching Back to Directory

Team at BioGeneration Ventures

20 professionals